Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 1
2012 1
2013 3
2014 3
2015 2
2017 1
2018 2
2019 1
2020 2
2024 6
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). European Association for the Study of the Liver (EASL), et al. J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7. J Hepatol. 2024. PMID: 38851997 Free article.
The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention …
The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and …
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma.
European Association for the Study of the Liver. European Association for the Study of the Liver. J Hepatol. 2025 Feb;82(2):315-374. doi: 10.1016/j.jhep.2024.08.028. Epub 2024 Dec 17. J Hepatol. 2025. PMID: 39690085 Review.
Integrating these innovations into clinical practice presents challenges and necessitates guidance. These clinical practice guidelines offer updated advice for managing patients with HCC and provide a comprehensive review of pertinent dat …
Integrating these innovations into clinical practice presents challenges and necessitates guidance. These clinical p …
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
European Association for the Study of the Liver. European Association for the Study of the Liver. J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18. J Hepatol. 2017. PMID: 28427875
Hepatitis B virus (HBV) infection remains a global public health problem with changing epidemiology due to several factors including vaccination policies and migration. This Clinical Practice Guideline presents updated recommendations for the optimal management …
Hepatitis B virus (HBV) infection remains a global public health problem with changing epidemiology due to several factors including vaccina …
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
European Association for the Study of the Liver; European Association for the Study of Diabetes; European Association for the Study of Obesity. European Association for the Study of the Liver, et al. Diabetologia. 2024 Nov;67(11):2375-2392. doi: 10.1007/s00125-024-06196-3. Diabetologia. 2024. PMID: 38869512 Free PMC article.
The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention …
The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and …
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). European Association for the Study of the Liver (EASL), et al. Obes Facts. 2024;17(4):374-444. doi: 10.1159/000539371. Epub 2024 Jun 7. Obes Facts. 2024. PMID: 38852583 Free PMC article.
The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention …
The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and …
Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India.
Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, Alam S, Bavdekar A, Dhiman RK, Eapen CE, Goyal V, Mohan N, Kandadai RM, Sathiyasekaran M, Poddar U, Sibal A, Sankaranarayanan S, Srivastava A, Thapa BR, Wadia PM, Yachha SK, Dhawan A. Nagral A, et al. J Clin Exp Hepatol. 2019 Jan-Feb;9(1):74-98. doi: 10.1016/j.jceh.2018.08.009. Epub 2018 Sep 3. J Clin Exp Hepatol. 2019. PMID: 30765941 Free PMC article. Review.
Clinical practice guidelines for Wilson's disease (WD) have been published by the American Association for the Study of Liver Diseases and European Association for the Study of the Liver in 2008 and 2012, respectively. ...Ri …
Clinical practice guidelines for Wilson's disease (WD) have been published by the American Association for the …
Updated Guidelines for the Prevention and Management of Chronic Hepatitis B-World Health Organization 2024 Compared With China 2022 HBV Guidelines.
Wong GL. Wong GL. J Viral Hepat. 2024 Dec;31 Suppl 2:13-22. doi: 10.1111/jvh.14032. Epub 2024 Nov 6. J Viral Hepat. 2024. PMID: 39503252 Review.
The year 2024 is the year of new clinical practice and management guidelines for chronic hepatitis B virus (HBV) infection. World Health Organization (WHO) published the updated HBV guidelines in March 2024. In contrast, two key international so …
The year 2024 is the year of new clinical practice and management guidelines for chronic hepatitis B virus (HBV) …
Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
Kudo M, Okanoue T; Japan Society of Hepatology. Kudo M, et al. Oncology. 2007;72 Suppl 1:2-15. doi: 10.1159/000111702. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087177 Review.
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but worldwide. Clinical Practice Guidelines for HCC were published in 2001 by the European Society of Study of the Liver (EASL) an …
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but worldwide. Clinical Pract …
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.
Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. Xie DY, et al. Hepatobiliary Surg Nutr. 2020 Aug;9(4):452-463. doi: 10.21037/hbsn-20-480. Hepatobiliary Surg Nutr. 2020. PMID: 32832496 Free PMC article. Review.
Recently, the guidelines for the management of Chinese HCC patients were updated. OBJECTIVE: The past decade has witnessed a great improvement in the management of hepatocellular carcinoma (HCC). ...EVIDENCE REVIEW: The updated recommendations o …
Recently, the guidelines for the management of Chinese HCC patients were updated. OBJECTIVE: The past decade has witnes …
21 results